- Home
- NVVEW vs SRPT Comparison
NVVEW vs SRPT Comparison
Compare NVVEW & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVVEW
- SRPT
- Stock Information
- Founded
- NVVEW N/A
- SRPT 1980
- Country
- NVVEW China
- SRPT United States
- Employees
- NVVEW 12
- SRPT N/A
- Industry
- NVVEW Oil Refining/Marketing
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- NVVEW Energy
- SRPT Health Care
- Exchange
- NVVEW Nasdaq
- SRPT Nasdaq
- Market Cap
- NVVEW N/A
- SRPT 1.7B
- IPO Year
- NVVEW 2020
- SRPT 1997
- Fundamental
- Price
- NVVEW $0.02
- SRPT $17.97
- Analyst Decision
- NVVEW
- SRPT Buy
- Analyst Count
- NVVEW 0
- SRPT 25
- Target Price
- NVVEW N/A
- SRPT $61.57
- AVG Volume (30 Days)
- NVVEW N/A
- SRPT 8.0M
- Earning Date
- NVVEW N/A
- SRPT 08-06-2025
- Dividend Yield
- NVVEW N/A
- SRPT N/A
- EPS Growth
- NVVEW N/A
- SRPT N/A
- EPS
- NVVEW N/A
- SRPT N/A
- Revenue
- NVVEW N/A
- SRPT $2,233,371,000.00
- Revenue This Year
- NVVEW N/A
- SRPT $26.87
- Revenue Next Year
- NVVEW N/A
- SRPT $3.15
- P/E Ratio
- NVVEW N/A
- SRPT N/A
- Revenue Growth
- NVVEW N/A
- SRPT 59.15
- 52 Week Low
- NVVEW N/A
- SRPT $16.88
- 52 Week High
- NVVEW N/A
- SRPT $154.13
- Technical
- Relative Strength Index (RSI)
- NVVEW N/A
- SRPT 28.43
- Support Level
- NVVEW N/A
- SRPT $17.31
- Resistance Level
- NVVEW N/A
- SRPT $19.74
- Average True Range (ATR)
- NVVEW 0.00
- SRPT 1.04
- MACD
- NVVEW 0.00
- SRPT 0.87
- Stochastic Oscillator
- NVVEW 0.00
- SRPT 45.83
About NVVEW Nuvve Holding Corp. Warrant
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.